aarti drugs #ANDA #BSE #Business #Pharma #USFDA
Aarti Drugs receives five observations in Form 483 from USFDA for its Himachal Pradesh facility
Aarti Drugs said in an exchange filing that the company has received five observations in Form 483 from the United State…